Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is the most common hair loss in women, often linked to low iron, while tight hairstyles and headscarves increase traction alopecia risk.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Stopping finasteride improved seizure control, suggesting neurosteroids affect seizures and treatment.

Removing breast implants resolved the patient's symptoms.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Rifampicin effectively treated tufted hair folliculitis with no relapse after one year.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

A child lost eyelashes on one eyelid after COVID-19, likely due to a temporary hair loss condition.

A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

A rare type of skin lymphoma was identified, affecting hair follicles and sweat glands.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Eyelash loss can be a sign of thyroid problems.

A rare scalp condition was successfully treated with specific medications after 9 months.

Long-term etretinate use may cause delayed wound healing and extra tissue growth after injury.

Isotretinoin reduced inflammation in tufted hair folliculitis, but hair tufting remained.

Finasteride can cause a unique skin reaction on the penile shaft.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Hair transplant surgery can cause temporary hair loss in the area where hair was taken from.

Chronic scalp lesions with crusts and pus that heal with strong topical steroids suggest Erosive Pustular Dermatosis, confirmed by biopsy showing specific immune cells.

Low ferritin and vitamin D levels are linked to hair loss, suggesting the need for personalized nutrition and diagnostics.

A woman got a skin condition from misusing a steroid cream, which improved after she stopped using it and started a new treatment.

"Alpenta" effectively reduces hair loss and improves hair growth in women with telogen effluvium.

Latanoprost eye drops caused excessive cheek hair growth and eyelash whitening in a woman.

The man's skin condition was finally identified as tinea incognito, a fungal infection.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.